TGTX
TG Therapeutics Inc
-19.05%
$18.43 - $14.92
Feb 7th 2023 - Mar 21st 2023
positive
negative
Jan, 6, 2023
Blood thinner Eliquis captured significant market ... See more
Jan, 4, 2023
$TGTX paid troll for Goldman or BOA, superb labeli... See more
positive
negative
No reviews available.
positive
negative
Dec, 16, 2022
I just love watching my profiles fly out the window..
positive
negative
Jan, 6, 2023
Blood thinner Eliquis captured significant market from Xarelto due to its safety profile.
Jan, 4, 2023
$TGTX paid troll for Goldman or BOA, superb labeling with excellent safety profile and no warning
Jan, 4, 2023
Imagine how much Ubli could be worth to BP now with Briumvi’s best in class product profile.
Dec, 30, 2022
Clear best in class profile, less of a burdensome for pts, less time at care centers and less expensive for providers.